MDA-MB-231 CDH11-expressing breast cancer cells were inoculated into nude mice and treated MatrigelTM with a function-blocking monoclonal CDH11-specific antibody that does not exhibit significant side-effects in inflammatory RA, or control IgG [6]. This evidence concerns the gene CDH11 and rheumatoid arthritis.